期刊文献+

清热解毒汤加减治疗急性盆腔炎性疾病54例

Fifty-Four Cases with Acute Pelvic Inflammatory Disease Treated with Modified Heat-Clearing and Detoxification Decoction
下载PDF
导出
摘要 目的:观察清热解毒汤加减治疗急性盆腔炎性疾病的临床疗效。方法:选择2011年12月—2013年12月就诊于本院的108例急性盆腔炎性疾病患者为研究对象,随机分为对照组和观察组,每组各54例。对照组给予常规西医治疗,观察组在对照组的基础上加用清热解毒汤治疗。比较两组患者的临床疗效,观察两组患者治疗前后在外周白细胞(white blood cell,WBC)和中性粒细胞计数,血沉(erythrocyte sedimentation rate,ESR)和C反应蛋白(C reactive protein,CRP)变化情况。B超检测两组患者治疗前后盆腔积液和盆腔包块消失或减少情况。结果:观察组有效率为94.44%,对照组有效率为79.63%,两组患者临床疗效比较,差异具有统计学意义(P<0.05)。两组患者治疗后WBC、中性粒细胞计数、CRP、ESR较治疗前下降,且观察组低于对照组,差异具有统计学意义(P<0.05);两组治疗后盆腔积液和盆腔包块显著少于治疗前,且观察组少于对照组,差异具有统计学意义(P<0.05)。结论:清热解毒汤加减治疗急性盆腔炎性疾病临床效果显著,可显著改善患者的临床症状。 Objective :To investigate the clinical effects of Modified Heat-Clearing and Detoxification Decoction on acute pelvic in- flammatory disease. Methods :Totally 108 cases with acute pelvic inflammatory disease patients treated in this hospital between De- cember 2011 and December 2013 were selected and divided randomly into control group and observation group,54 cases in each group. Control group were given conventional western medicine for the treatment while observation group were additionally given Modified Heat-Clearing and Detoxification Decoction. The clinical effects of the two groups were compared. The changes of WBC count,neutrophil count,ESR and CRP in both groups after treatment were observed. Results:The effective rate was 94.44% in observation group and 79.63% in control group ;the difference had statistical significance ( P 〈 0.05 ). The WBC count, neutro- phil count, ESR and CRP in both groups declined,and observation group were lower than control group;the difference had statisti- cal significance ( P 〈 0.05 ). The symptoms of pelvic effusion and lumps decreased significantly after treatment in both groups, and observation group were less than control group;the difference had statistical significance (P 〈 0.05 ). Conclusion:Modified Heat- Clearing and Detoxification Decoction has significant therapeutic effects on acute pelvic inflammatory disease, which can improve the clinical symptoms of the patients.
作者 付娟
机构地区 房县人民医院
出处 《河南中医》 2017年第12期2156-2158,共3页 Henan Traditional Chinese Medicine
基金 湖北省科技规划项目(编号:HK20140918)
关键词 急性盆腔炎性疾病 清热解毒汤 C反应蛋白 血沉 acute pelvic inflammatory disease Heat-Clearing and Detoxification Decoction CRP ESR
  • 相关文献

参考文献7

二级参考文献15

  • 1柏文红,王伟,李家福.金刚藤胶囊治疗慢性盆腔炎140例疗效观察[J].中国全科医学,2006,9(14):1163-1163. 被引量:8
  • 2徐叔云 卞如濂 等.药理实验方法学[M].北京:人民卫生出版社,1993.525-541.
  • 3陈奇.中国药理研究方法学[M].北京:人民卫生出版社,1994.536.
  • 4马诸荣 苏德模.药品微生物学检验手册[M].北京:科学出版社,2000.197-210.
  • 5乐杰.妇产科学[M].第6版.北京:人民卫生出版社,2009:182.
  • 6郎景和,向阳主译.妇科学[M].第14版.北京:人民卫生出版社,2010:349.
  • 7曹泽毅.中华妇产科学[M].第2版.北京:人民卫生出版社,2005,1457.
  • 8Goicoechea M, de Vinuesa S G, lhera V, et al. Effects of atorvas- tatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease [ J ]. Journal of the American Society of Nephrology,2006,17 ( 12 suppl 3 ) : S231 - S235.
  • 9Goudevenos J A, Bairaktari E T, Chatzidimou K G, et al. The effect of atorvastatin on serum lipids, lipoprotein (a) and plasma fibrino- gen levels in primary dyslipidaemia - a pilot study involving serial sampling[ J]. Current Medical Research and Opinion, 2000, 16 (4) : 269 -275.
  • 10狄文,吴霞.美国疾病与预防控制中心2006版盆腔炎性疾病诊治指南解读[J].中国实用妇科与产科杂志,2008,24(4):241-243. 被引量:70

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部